Article info
Original article
Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy
- Correspondence to Dr Zhaomin Xu, Surgical Health Outcomes & Research Enterprise, Department of Surgery, University of Rochester Medical Center, 601 Elmwood Avenue, Box SURG, Rochester, NY 14642, USA; zhaomin_xu{at}urmc.rochester.edu
Citation
Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy
Publication history
- Received July 5, 2016
- Revised November 8, 2016
- Accepted November 13, 2016
- First published December 8, 2016.
Online issue publication
June 14, 2020
Article Versions
- Previous version (22 June 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/